Form D — Entero Therapeutics, Inc.
0001104659-25-079619 · filed 2025-08-18
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $3,025,000
- Total sold
- $3,025,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Entero Therapeutics, Inc.
- CIK
- 1604191
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 79014TH ST N # 21135
ST. PETERSBURG, FL 33702 - Phone
- 561-589-7020
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Richard Paolone · Executive OfficerSt. Petersburg, FL Find on LinkedIn ↗
-
Edward Borkowski · DirectorSt. Petersburg, FL Find on LinkedIn ↗
-
Eric Corbett · DirectorSt. Petersburg, FL Find on LinkedIn ↗
-
Manpreet Uppal · DirectorSt. Petersburg, FL Find on LinkedIn ↗
-
Jack Syage · DirectorSt. Petersburg, FL Find on LinkedIn ↗
-
Anna Skowron · Executive OfficerSt. Petersburg, FL Find on LinkedIn ↗
-
Jason Sawyer · DirectorSt. Petersburg, FL Find on LinkedIn ↗
-
Geordan Pursglove · DirectorSt. Petersburg, FL Find on LinkedIn ↗
View original on SEC EDGAR.